GENSCI098
Clinical trials for GENSCI098 explained in plain language.
Never miss a new study
Get alerted when new GENSCI098 trials appear
Sign up with your email to follow new studies for GENSCI098, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection for Graves' disease enters first human tests
Disease control Recruiting nowThis early-stage trial tests a single injection of a new drug called GenSci098 in 24 adults with Graves' disease, a condition where the thyroid is overactive. The main goal is to check safety and side effects over about 5 months. Researchers will also measure how the drug moves t…
Matched conditions: GENSCI098
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug GenSci098 enters first human trial for thyroid eye disease
Disease control Recruiting nowThis early-stage trial is testing a new drug called GenSci098 in 76 adults with active thyroid eye disease (TED). The main goal is to check the drug's safety and how the body processes it at different doses. Participants will receive either the drug or a placebo as a shot under t…
Matched conditions: GENSCI098
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC